Chronic obstructive pulmonary disease (COPD) is a prevalent condition in the United States, affecting 16 million adults as reported by the Centers for Disease Control. This disease, particularly emphysema, is a leading cause of death. Mercy Health in Youngstown, Ohio, is now offering the region’s first new treatment for patients with emphysema.
The Zephyr Endobronchial Valves are being used by Mercy Health to help Valley residents battle COPD. This new treatment involves a minimally invasive procedure to place valves into the damaged areas of the lung. The significance of this treatment lies in the fact that it is the first FDA-approved procedure that can help COPD patients improve their quality of life without the risks associated with major surgeries like lung transplants.
Dr. Niraj Niraula, a pulmonologist at Mercy Health, believes that this procedure has the potential to be life-changing for patients who continue to experience symptoms despite taking medications as directed. Many patients with COPD experience trapped air in damaged areas of their lungs, leading to extreme shortness of breath. This can result in difficulty performing daily activities like walking, eating, or bathing.
Before the introduction of the Zephyr Endobronchial Valves, the only options available for such patients were highly invasive treatments like lung volume reduction surgery or lung transplantation. However, this minimally invasive procedure offers a shorter recovery time and lowers the risk of infection. The procedure typically takes under an hour and does not involve any cutting or incisions.
For more information about Mercy Health’s pulmonology services and team, visit their website at https://www.mercy.com/health-care-services/pulmonology.